Company Quick10K Filing
Teleflex
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 47 $15,750
10-Q 2019-10-31 Quarter: 2019-09-29
10-Q 2019-08-01 Quarter: 2019-06-30
10-Q 2019-05-02 Quarter: 2019-03-31
10-K 2019-02-21 Annual: 2018-12-31
10-Q 2018-11-01 Quarter: 2018-09-30
10-Q 2018-08-02 Quarter: 2018-07-01
10-Q 2018-05-03 Quarter: 2018-04-01
10-K 2018-02-22 Annual: 2017-12-31
10-Q 2017-11-02 Quarter: 2017-10-01
10-Q 2017-08-03 Quarter: 2017-07-02
10-Q 2017-05-04 Quarter: 2017-04-02
10-K 2017-02-23 Annual: 2016-12-31
10-Q 2016-10-27 Quarter: 2016-09-25
10-Q 2016-07-28 Quarter: 2016-06-26
10-Q 2016-04-28 Quarter: 2016-03-27
10-K 2016-02-25 Annual: 2015-12-31
10-Q 2015-10-29 Quarter: 2015-09-27
10-Q 2015-07-30 Quarter: 2015-06-28
10-Q 2015-04-30 Quarter: 2015-03-29
10-K 2015-02-20 Annual: 2014-12-31
10-Q 2014-10-29 Quarter: 2014-09-28
10-Q 2014-07-30 Quarter: 2014-06-29
10-Q 2014-04-30 Quarter: 2014-03-30
10-K 2014-02-24 Annual: 2013-12-31
10-Q 2013-10-30 Quarter: 2013-09-29
10-Q 2013-07-31 Quarter: 2013-06-30
10-Q 2013-04-30 Quarter: 2013-03-31
10-K 2013-02-22 Annual: 2012-12-31
10-Q 2012-10-31 Quarter: 2012-09-30
10-Q 2012-07-31 Quarter: 2012-07-01
10-Q 2012-05-01 Quarter: 2012-04-01
10-K 2012-02-24 Annual: 2011-12-31
10-Q 2011-10-25 Quarter: 2011-09-25
10-Q 2011-07-27 Quarter: 2011-06-26
10-Q 2011-04-26 Quarter: 2011-03-27
10-Q 2010-10-27 Quarter: 2010-09-26
10-Q 2010-07-23 Quarter: 2010-06-27
10-Q 2010-04-28 Quarter: 2010-03-28
10-K 2010-02-25 Annual: 2009-12-31
8-K 2019-11-15 Other Events, Exhibits
8-K 2019-10-31 Earnings, Regulation FD, Other Events, Exhibits
8-K 2019-08-06 Other Events
8-K 2019-08-01 Earnings, Regulation FD, Exhibits
8-K 2019-05-03 Shareholder Vote
8-K 2019-05-02 Earnings, Regulation FD, Exhibits
8-K 2019-04-05 Enter Agreement, Exhibits
8-K 2019-02-26 Other Events
8-K 2019-02-21 Earnings, Regulation FD, Exhibits
8-K 2019-02-18 Other Events, Exhibits
8-K 2018-12-10 Officers
8-K 2018-11-01 Earnings, Regulation FD, Exhibits
8-K 2018-10-04 Off-BS Arrangement
8-K 2018-07-31 Earnings, Officers, Regulation FD, Exhibits
8-K 2018-06-22 Officers, Exhibits
8-K 2018-05-31 Officers
8-K 2018-05-21 Other Events
8-K 2018-05-11 Regulation FD, Exhibits
8-K 2018-05-04 Shareholder Vote
8-K 2018-05-03 Earnings, Regulation FD, Exhibits
8-K 2018-03-13 Other Events
8-K 2018-02-22 Earnings, Regulation FD, Other Events, Exhibits
8-K 2018-02-19 Officers

Teleflex Financials

TFX Metrics, Comps, Filings

Annual | Quarterly

Business

Teleflex Incorporated is referred to herein as "we," "us," "our," "Teleflex" and the "Company."

Teleflex is a global provider of medical technology products that enhance clinical benefits, improve patient and provider safety and reduce total procedural costs. We primarily design, develop, manufacture and supply single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. We market and sell our products to hospitals and healthcare providers worldwide through a combination of our direct sales force and distributors. Because our products are used in numerous markets and for a variety of procedures, we are not dependent upon any one end-market or procedure. We manufacture our products at approximately 35 manufacturing sites, with major manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States (the "U.S.").

We are focused on achieving consistent, sustainable and profitable growth and improving our financial performance by increasing our market share and improving our operating efficiencies through:


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Annual)

Operating, Investing, Financing

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
ResMed (RMD) 17,425 59% 21.9 10% 4,108 2,035 2,607 1,537 405 848 18,540
Teleflex (TFX) 15,750 57% 29.3 4% 6,314 3,650 2,521 1,426 271 600 17,595
Dentsply Sirona (XRAY) 13,003 52% 29.7 1% 8,575 3,392 3,944 2,041 105 478 14,194
Dexcom (DXCM) 12,908 63% -140.0 -8% 2,066 1,378 1,222 767 -170 -87 12,198
ABIOMED (ABMD) 11,806 83% 35.8 23% 1,125 122 797 661 258 327 11,705
Insulet (PODD) 7,136 66% 163.9 2% 978 728 661 435 17 47 7,624
Hill-Rom Holdings (HRC) 7,067 49% 25.9 5% 4,575 2,951 2,884 1,415 215 335 8,663
Haemonetics (HAE) 6,085 46% 35.9 4% 1,260 669 977 450 49 176 6,331
Penumbra (PEN) 6,047 67% 257.6 3% 585 131 495 332 15 23 5,969
Novocure (NVCR) 5,679 72% -357.0 -10% 406 247 294 212 -41 -16 5,646
ICU Medical (ICUI) 5,345 39% 39.5 3% 1,623 305 1,311 508 47 127 5,031
Integra Lifesciences (IART) 4,669 62% 20.6 3% 3,290 1,869 1,493 930 101 262 5,393
Globus Medical (GMED) 4,300 77% 18.9 10% 1,391 103 743 573 143 221 4,182
Cantel Medical (CMD) 3,630 47% 30.3 5% 1,070 409 918 427 55 126 3,816
Tandem Diabetes Care (TNDM) 3,601 52% -70.5 -22% 255 110 282 147 -55 -49 3,470
Merit Medical Systems (MMSI) 3,357 45% 26.4 2% 1,736 786 949 423 39 141 3,722
Nuvasive (NUVA) 3,283 72% 19.4 3% 1,805 1,127 814 52 194 3,765
Glaukos (GKOS) 2,779 87% -384.5 -4% 302 114 211 182 -12 -7 2,730
Nevro (NVRO) 1,957 69% -26.5 -21% 448 246 379 261 -93 -77 2,049
iRhythm Technologies (IRTC) 1,941 75% -48.5 -21% 207 159 182 137 -44 -40 1,923

Balance Sheet ($MM)2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash20811521400159357
Accounts Receivable2940-99011249346366
Inventory339107-1621120420500428
PP&E288816867967517532433
Assets3,6435,516-10,9997,2007,0067,2947,5449,3256,278
Accounts Payable85388-993463328547107
Long-Term Debt8861,1221,1651,3301,1051,0891,0332,2502,176
Liabilities1,8563,535-4,4621,7691,7551,9865,4047,0303,738
Stockholders' Equity1,7831,981-6,5375,4315,2505,3072,138
Income Statement ($MM)2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Revenue1,802805-2341,0011,0791,079002,448
Cost of Revenue1,008467-233582653646001,064
Gross Profit794338-1419426433001,384
R&D4374956413011106
SG&A4754002853263364447879
Tax22-74-1436956244923
Net Income202323-200248300345237153201
Cash Flow ($MM)2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash Operating207-110239-148323135-85-51435
Cash Investing148-3-115-299-44-935-511-196
Cash Financing-337218-123148-293-4275591-206